Robin Hood Ventures is a group of angel investors focused on early-stage and high-growth companies in the Greater Philadelphia region. The company generally invests $250,000 to $1,000,000. It invests in the IT services and software, life sciences and financial technology sectors.
BioCrossroads is a venture capital firm invests in life sciences industry based in Indiana. The firm operates early-stage life sciences venture funds investing in early-stage biotechnology, pharmaceutical, medical device, diagnostic, agtech, biotech and health information technology products and platforms.
Innovacorp is an incubator and an early-stage venture capital firm. The firm invests in the information technology, clean technology, life sciences and ocean technology sectors. The firm was founded in the year 1995 and it is based in Halifax, Canada.
Borealis Ventures is a venture capital firm headquartered in Hanover, New Hampshire and with an additional office in Boston, Massachusetts. The firm focuses on investing in companies operating within the healthcare space, including digital health and life sciences, and the "Built Environment" space, including construction technology, design & engineering software, 3D design, property tech and smart city software sectors.
Lux Capital Management is a research-driven investment firm focused on founding, seed and early stage investments in the physical and life sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high growth sectors. Our investment team has built over 20 companies from scratch. Lux's investment strategy ensures our portfolio companies are better connected, have deeper insight, and command industry leadership faster than their competitors.
Kreos Capital is an investment firm focuses on growth capital investments. The firm invests in the clean technology, communication, consumer, life sciences, semiconductor, hardware and software sectors. It was founded in 1998 and is based in England, London.
Andy Palmer is a serial entrepreneur who specializes in accelerating the foundation and growth of early-stage, mission-driven companies. He has helped start, fund or found more than 50 innovative companies in technology, health care and the life sciences. Andy founded Koa Lab, a start-up fund in the heart of Harvard Square, Cambridge, Mass.; and co-founded Tamr, with Turing Award winner MIT professor Michael Stonebraker. Andy was named Angel of the Year in the New England Venture Capital Association‘s 2013 NEVY Awards.
CapDecisif Management is a venture capital firm based in Paris, France and was founded in 2001. The firm invests in companies operating in the technology, biotechnology, healthcare, information and communication, software, life sciences and engineering sectors.
Vulcan Capital is a private equity and venture capital firm and investment arm of Paul Allen based in Seattle, Washington. The firm focuses on investing in all stages of corporate development through leveraged buyouts, growth capital, turnarounds and early-stage venture capital. The firm invests in the financial services, internet technology, life sciences, media, communication and consumer sectors. It was established in 2003 and operates as an investment arm of Vulcan.
WRF Capital is the venture capital arm of Washington Research Foundation and it specializes in early-stage investments. The firm focuses on investing in companies based in Washington. While actively seeking investments in companies operating in life sciences and enabling technologies, the firm on an exceptional basis invest in companies in the physical sciences, energy, and information technology sectors. The firm was founded in 1981 and is based in Seattle, Washington.
Founded in 1973, Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. The company invests across all stages of company development including early and late-stage venture financing, growth equity, and public companies. With offices in London, Boston and Menlo Park, Abingworth has backed more than 100 developing life science/medical businesses, over two-thirds of which have gone public, merged, or been acquired. Abingworth has funds under management of more than $1.25 billion. The firm has raised eleven funds since it was founded in 1973, the last nine of which have been entirely dedicated to life sciences and healthcare. Abingworth's investments are based in the U.S. and Europe including the U.K., Belgium, Denmark, France, Germany, Holland and Sweden. The firm's investments range from $20-80 million over more than one round of financing. In February 2014, the firm announced the final closing of its POUND 225M ($375M) fund, Abingworth Bioventures VI (ABV VI). ABV VI is Abingworth's 10th life sciences fund.
BioAccel is a non-profit organization and an accelerator that provides funding and business expertise to develop early stage life science technologies that drive local economic development efforts. The firms invests in life sciences and research and technology companies focusing on biomedical, medical devices, tools, diagnostic platforms and service sectors. It is based in Phoenix, Arizona.
Dave Mawhinney serves as Executive Director at Carnegie Mellon University. Dave Mawhinney is executive director, Swartz Center for Entrepreneurship, and executive director, Donald H. Jones Center for Entrepreneurship. He serves as the managing director, Open Field Entrepreneurs Fund, and director, i6 Agile Innovation System, a collaboration between InnovationWorks and CMU. Dave is also associate teaching professor at the Carnegie Mellon Tepper School of Business. Prior to joining Carnegie Mellon, Dave was co-founder, chairman and CEO of mSpoke, an internet content and advertising recommendation engine, that was acquired in 2010 by LinkedIn, the world's leading professional social networking site. In 2006, Morgan Stanley's MSCI/Barra business unit acquired mSpoke's first business line, a quantitative investment recommendation engine. Before mSpoke, Dave was general partner of PNC Technology Investors. Earlier in his career, he co-founded three successful startup ventures, including Premier Health Exchange (acquired by Medibuy), Hawk Medical (acquired by McKesson), and Industry.Net (merged with AT&T Business Network to form Nets, Inc.). Dave is an active board member at MedSage Technologies (now NewCare Solutions LLC), EZ-FLO Injection Systems and the Indiana University of Pennsylvania Alumni Association (ex-officio, past president). He is an Advisory board member to InnovationWork's AlphaLab, Pittsburgh Equity Partners and Carnegie Mellon University's Project Olympus. Dave also served as Executive-in-residence at the Pittsburgh Life Sciences Greenhouse, working with healthcare information technology startups. Dave holds an MBA with Distinction from Carnegie Mellon University and a B.S. in physics, Summa Cum Laude, from Indiana University of Pennsylvania. Dave was a 2017 recipient of the Tepper School Alumni Award.
HealthCap Ventures is a venture capital firm that invests in the healthcare, life sciences, nanotechnology, mobile and information technology sectors. It was founded in 1996 and is headquartered in Stockholm, Sweden.